These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 454482)

  • 21. Decrease of the in vitro drug-metabolizing activity of the hepatic mixed function oxidase system in rats infected experimentally with Fasciola hepatica: pharmacological implications.
    Maffei Facino R; Carini M; Bertuletti R; Genchi C; Malchiodi A
    Pharmacol Res Commun; 1981 Sep; 13(8):731-42. PubMed ID: 6794045
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of phenobarbital pretreatment on mixed function oxidases & lipid peroxidation during thiodemeton toxicity.
    Fawade MM; Pawar SS
    Indian J Exp Biol; 1980 Jun; 18(6):645-7. PubMed ID: 7439951
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of cyanoketone on digitoxin-induced mortality and hepatic mixed function oxidases in rats.
    Stohs SJ; Reinke LA; Small LD; Hassing JM
    Arch Int Pharmacodyn Ther; 1975 Nov; 218(1):120-4. PubMed ID: 1212011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of acrylamide on brain and hepatic mixed-function oxidases and glutathione-S-transferase in rats.
    Das M; Mukhtar H; Seth PK
    Toxicol Appl Pharmacol; 1982 Dec; 66(3):420-6. PubMed ID: 7167969
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of ethanol administration on renal and hepatic mixed-function oxidases in the Fischer 344 rat.
    Rush GF; Adler VL; Hook JB
    Toxicol Lett; 1982 Aug; 12(4):265-71. PubMed ID: 7135425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study on the effects of phenobarbital and 3,4-benzpyrene on the hydroxylating enzyme system of rat-liver microsomes.
    Gnosspelius Y; Thor H; Orrenius S
    Chem Biol Interact; 1969 Dec; 1(2):125-37. PubMed ID: 4400999
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of phenobarbital, 3-methylcholanthrene, and pregnenolone-16 alpha-carbonitrile on the N-demethylation and O-de-ethylation of [6-H3]ethylmorphine.
    Duquette PH; Peterson FJ; Erickson RR; Holtzman JL
    Drug Metab Dispos; 1981; 9(5):483-4. PubMed ID: 6117451
    [No Abstract]   [Full Text] [Related]  

  • 28. Dioxane-induced changes in mouse liver microsomal mixed function oxidase system.
    Pawar SS; Mungikar AM
    Bull Environ Contam Toxicol; 1976 Jun; 15(6):762-7. PubMed ID: 7331
    [No Abstract]   [Full Text] [Related]  

  • 29. A possible role of liver microsomal alkaline ribonuclease in the stimulation of oxidative drug metabolism by phenobarbital, chlordane and chlorophenothane (DDT).
    Lechner MC; Pousada CR
    Biochem Pharmacol; 1971 Nov; 20(11):3021-8. PubMed ID: 5132111
    [No Abstract]   [Full Text] [Related]  

  • 30. Repression of dimethylnitrosamine-demethylase by typical inducers of microsomal mixed-function oxidases.
    Arcos JC; Bryant GM; Venkatesan N; Argus MF
    Biochem Pharmacol; 1975 Aug; 24(16):1544-7. PubMed ID: 1191312
    [No Abstract]   [Full Text] [Related]  

  • 31. Kinetic alterations in rat liver microsomal cholecalciferol 25-hydroxylase associated with phenobarbital administration.
    Delvin EE; Arabian A; Glorieux FH
    Biochem Pharmacol; 1980 Feb; 29(3):441-5. PubMed ID: 6244839
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of alteration of rat hepatic mixed-function oxidase (MFO) activity on the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
    Beatty PW; Vaughn WK; Neal RA
    Toxicol Appl Pharmacol; 1978 Aug; 45(2):513-9. PubMed ID: 705787
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of silybin on the hepatic microsomal drug-metabolising enzyme system in the rat.
    Down WH; Chasseaud LF; Grundy RK
    Arzneimittelforschung; 1974 Dec; 24(12):1986-8. PubMed ID: 4218108
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatic microsomal mixed function oxygenase: enzyme multiplicity for the metabolism of carcinogens to DNA-binding metabolites.
    Gurtoo HL; Bejba N
    Biochem Biophys Res Commun; 1974 Nov; 61(2):735-42. PubMed ID: 4455244
    [No Abstract]   [Full Text] [Related]  

  • 35. Metabolism in vivo of dioxane: effect of inducers and inhibitors of hepatic mixed-function oxidases.
    Woo YT; Argus MF; Arcos JC
    Biochem Pharmacol; 1977 Aug; 26(16):1539-42. PubMed ID: 901573
    [No Abstract]   [Full Text] [Related]  

  • 36. Reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent formation and breakdown of hydrogen peroxide during mixed function oxidation reactions in liver microsomes.
    Hildebraunt AG; Roots I
    Arch Biochem Biophys; 1975 Dec; 171(2):385-97. PubMed ID: 955
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of atropine sulphate treatment on hepatic mixed function oxidase system during Baygon intoxication.
    Makhija SJ; Pawar SS
    Bull Environ Contam Toxicol; 1976 Jul; 16(1):90-7. PubMed ID: 963313
    [No Abstract]   [Full Text] [Related]  

  • 38. Evidence for the formation of a protein bound hydrodisulfide resulting from the microsomal mixed function oxidase catalyzed desulfuration of carbon disulfide.
    Catignani GL; Neal RA
    Biochem Biophys Res Commun; 1975 Jul; 65(2):629-36. PubMed ID: 238535
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of the drug metabolising ability of rat intestinal mucosal microsomes with that of liver.
    Shirkey RS; Chakraborty J; Bridges JW
    Biochem Pharmacol; 1979 Sep; 28(18):2835-9. PubMed ID: 497032
    [No Abstract]   [Full Text] [Related]  

  • 40. Microsomal drug-metabolizing enzyme activity in rats given alpha-(2,4-dichlorophenyl)-alpha-phenyl-5-pyrimidinemethanol for period of 14 days to 2 years.
    Hoffman DG; Bernhard NR; Worth HM; Emmerson JL
    Toxicol Appl Pharmacol; 1976 Mar; 35(3):413-21. PubMed ID: 178071
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.